These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27521807)

  • 41. A Randomized Trial of Contingency Management for Smoking Cessation During Intensive Outpatient Alcohol Treatment.
    Cooney JL; Cooper S; Grant C; Sevarino K; Krishnan-Sarin S; Gutierrez IA; Cooney NL
    J Subst Abuse Treat; 2017 Jan; 72():89-96. PubMed ID: 27542442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized Trial of Computerized Cognitive Behavioral Therapy for Alcohol Use Disorders: Efficacy as a Virtual Stand-Alone and Treatment Add-On Compared with Standard Outpatient Treatment.
    Kiluk BD; Devore KA; Buck MB; Nich C; Frankforter TL; LaPaglia DM; Yates BT; Gordon MA; Carroll KM
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1991-2000. PubMed ID: 27488212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of adherence to pharmacological and behavioral treatment in a cessation trial among smokers in Aleppo, Syria.
    Ben Taleb Z; Ward KD; Asfar T; Bahelah R; Maziak W
    Drug Alcohol Depend; 2015 Aug; 153():167-72. PubMed ID: 26077603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders.
    Witkiewitz K; Finney JW; Harris AH; Kivlahan DR; Kranzler HR
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1557-70. PubMed ID: 26250333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM; Weiss RD; Dundon W; Miller WR; Donovan D; Ernst DB; Rounsaville BJ
    J Stud Alcohol Suppl; 2005 Jul; (15):170-8; discussion 168-9. PubMed ID: 16223068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of a "psychotherapy with no pills" treatment condition as part of a combined pharmacotherapy-psychotherapy research study of alcohol dependence.
    Weiss RD; Locastro JS; Swift R; Zweben A; Miller WR; Longabaugh R; Hosking JD
    J Stud Alcohol Suppl; 2005 Jul; (15):43-9; discussion 33. PubMed ID: 16223055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Piracetam in alcoholic organic mental disorder: a placebo controlled study comparing two dosages.
    Fleischhacker WW; Günther V; Barnas C; Lieder F; Miller C
    Int Clin Psychopharmacol; 1986 Jul; 1(3):210-5. PubMed ID: 3549872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developing a baseline assessment battery: balancing patient time burden with essential clinical and research monitoring.
    Gastfriend DR; Donovan D; Lefebvre R; Murray KT
    J Stud Alcohol Suppl; 2005 Jul; (15):94-103; discussion 92-3. PubMed ID: 16223061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DAILY-A Personalized Circadian
    Hühne A; Hoch E; Landgraf D
    Front Psychiatry; 2020; 11():569864. PubMed ID: 33519541
    [No Abstract]   [Full Text] [Related]  

  • 50. Adding tools to the toolbox: The role of coping repertoire in alcohol treatment.
    Roos CR; Witkiewitz K
    J Consult Clin Psychol; 2016 Jul; 84(7):599-611. PubMed ID: 27054825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of group treatments for alcohol use disorders: a review.
    Orchowski LM; Johnson JE
    Curr Drug Abuse Rev; 2012 Jun; 5(2):148-57. PubMed ID: 22455506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploratory randomized controlled trial evaluating the impact of a waiting list control design.
    Cunningham JA; Kypri K; McCambridge J
    BMC Med Res Methodol; 2013 Dec; 13():150. PubMed ID: 24314204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time.
    Del Re AC; Maisel N; Blodgett JC; Wilbourne P; Finney JW
    J Clin Psychopharmacol; 2013 Oct; 33(5):649-57. PubMed ID: 23857312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Riboflavin as an independent and accurate biomarker for adherence in a randomized double-blind and placebo-controlled clinical trial.
    Ramanujam VS; Nayeem F; Anderson KE; Kuo YF; Chen NW; Ju H; Lu LW
    Biomarkers; 2017 Sep; 22(6):508-516. PubMed ID: 27918196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial.
    Kirkland AE; Browning BD; Green R; Liu H; Maralit AM; Ferguson PL; Meyerhoff DJ; Prisciandaro JJ; Miranda R; Brady KT; Tomko RL; Gray KM; Squeglia LM
    Neuropsychopharmacology; 2023 Jul; 48(8):1184-1193. PubMed ID: 36878996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Practical outpatient pharmacotherapy for alcohol use disorder.
    Kim Y; Hack LM; Ahn ES; Kim J
    Drugs Context; 2018; 7():212308. PubMed ID: 29445407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Double blind: double talk or are there ways to do better research.
    Ney PG; Collins C; Spensor C
    Med Hypotheses; 1986 Oct; 21(2):119-26. PubMed ID: 3641026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purpose-guided trial design in health-related behavioral intervention research.
    Freedland KE
    Health Psychol; 2020 Jun; 39(6):539-548. PubMed ID: 32212768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toward more responsive and effective intervention systems for alcohol-related problems.
    Humphreys K; Tucker JA
    Addiction; 2002 Feb; 97(2):126-32. PubMed ID: 11860378
    [No Abstract]   [Full Text] [Related]  

  • 60. Relative contribution of specific and nonspecific treatment effects: meta-analysis of placebo-controlled behavior therapy research.
    Bowers TG; Clum GA
    Psychol Bull; 1988 May; 103(3):315-23. PubMed ID: 3289070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.